Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Maggioni, AP; Dahlström, U; Filippatos, G; Chioncel, O; Crespo Leiro, M; Drozdz, J; Fruhwald, F; Gullestad, L; Logeart, D; Fabbri, G; Urso, R; Metra, M; Parissis, J; Persson, H; Ponikowski, P; Rauchhaus, M; Voors, AA; Nielsen, OW; Zannad, F; Tavazzi, L; Heart Failure Association of the European Society of Cardiology (HFA).
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).
Eur J Heart Fail. 2013; 15(7):808-817
Doi: 10.1093/eurjhf/hft050
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fruhwald Friedrich
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The ESC-HF Pilot survey was aimed to describe clinical epidemiology and 1-year outcomes of outpatients and inpatients with heart failure (HF). The pilot phase was also specifically aimed at validating structure, performance, and quality of the data set for continuing the survey into a permanent Registry. The ESC-HF Pilot study is a prospective, multicentre, observational survey conducted in 136 Cardiology Centres in 12 European countries selected to represent the different health systems across Europe. All outpatients with HF and patients admitted for acute HF on 1 day per week for eight consecutive months were included. From October 2009 to May 2010, 5118 patients were included: 1892 (37) admitted for acute HF and 3226 (63) patients with chronic HF. The all-cause mortality rate at 1 year was 17.4 in acute HF and 7.2 in chronic stable HF. One-year hospitalization rates were 43.9 and 31.9, respectively, in hospitalized acute and chronic HF patients. Major regional differences in 1-year mortality were observed that could be explained by differences in characteristics and treatment of the patients. The ESC-HF Pilot survey confirmed that acute HF is still associated with a very poor medium-term prognosis, while the widespread adoption of evidence-based treatments in patients with chronic HF seems to have improved their outcome profile. Differences across countries may be due to different local medical practice as well to differences in healthcare systems. This pilot study also offered the opportunity to refine the organizational structure for a long-term extended European network.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Cardiovascular Agents - therapeutic use
- Cardiovascular Agents - epidemiology
- Female -
- Follow-Up Studies -
- Heart Failure - drug therapy
- Hospital Mortality - trends
- Hospitalization - statistics & numerical data
- Humans -
- Inpatients -
- Male -
- Middle Aged -
- Pilot Projects -
- Prognosis -
- Prospective Studies -
- Registries -
- Time Factors -
- Find related publications in this database (Keywords)
- Acute heart failure
- Chronic heart failure
- Prognosis
- Observational studies
- Pharmacological treatments